1998
Morphologic, Immunophenotypic, and Molecular Evaluation of Bone Marrow Involvement in Non-Hodgkin's Lymphoma
Crotty P, Smith B, Tallini G. Morphologic, Immunophenotypic, and Molecular Evaluation of Bone Marrow Involvement in Non-Hodgkin's Lymphoma. Applied Immunohistochemistry & Molecular Morphology 1998, 7: 90-95. PMID: 9785007, DOI: 10.1097/00019606-199804000-00005.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, CDBiomarkers, TumorBone MarrowBone Marrow ExaminationClone CellsFlow CytometryGene Rearrangement, B-LymphocyteGene Rearrangement, T-LymphocyteHumansImmunophenotypingLymphoma, B-CellLymphoma, Non-HodgkinLymphoma, T-CellNeoplasm ProteinsNeoplastic Stem CellsPolymerase Chain ReactionSensitivity and SpecificityConceptsPrimer polymerase chain reactionMarrow involvementT-cell neoplasiaFlow cytometryB-cell neoplasiaObjective evidenceT-cell receptor gene rearrangementsBone marrow involvementConsensus primer polymerase chain reactionNon-Hodgkin lymphomaChronic lymphocytic leukemiaB-cell lymphomaT-cell neoplasmsB-cell neoplasmsReceptor gene rearrangementsDetection of clonalityDetectable diseaseHodgkin's lymphomaPolymerase chain reactionLymphocytic leukemiaApparent diseaseLymphomaPatientsImportant adjunctNeoplasia
1990
Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Wheeler C, Antin JH, Churchill WH, Come SE, Smith BR, Bubley GJ, Rosenthal DS, Rappaport JM, Ault KA, Schnipper LE. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study. Journal Of Clinical Oncology 1990, 8: 648-56. PMID: 2313334, DOI: 10.1200/jco.1990.8.4.648.Peer-Reviewed Original ResearchConceptsAutologous bone marrow transplantationMaximum-tolerated doseBone marrow transplantationRelapsed lymphomaComplete responseMarrow transplantationDose levelsVP-16Refractory Hodgkin's diseaseTreatment-related mortalityDose-finding studyAssessable patientsAcceptable toxicityConditioning regimenInterstitial pneumonitisHodgkin's diseaseResidual diseaseHodgkin's lymphomaPatient populationDisease progressionHigh dosePatientsLymphomaDiseaseCBV
1989
Flow cytometric surface light chain analysis of lymphocyte‐rich effusions. A useful adjunct to cytologic diagnosis
Ibrahim R, Teich D, Smith B, Antin J, Olivier A, Weinberg D. Flow cytometric surface light chain analysis of lymphocyte‐rich effusions. A useful adjunct to cytologic diagnosis. Cancer 1989, 63: 2024-2029. PMID: 2495164, DOI: 10.1002/1097-0142(19890515)63:10<2024::aid-cncr2820631026>3.0.co;2-h.Peer-Reviewed Original ResearchConceptsLymphocyte-rich effusionsLight chain analysisCytologic diagnosisFalse-positive resultsCytologic studyFalse negative rateCell marker studiesSmall lymphocytic lymphomaBody cavity fluidsClinical outcomesLymphoproliferative disordersLymphocytic lymphomaLymphatic leukemiaCytologic evaluationSmall lymphocytesCytologic analysisBenign effusionsUseful adjunctClinical diagnosisPatientsEffusionLymphomaDiagnosisMarker studiesCavity fluid
1984
Circulating Monoclonal B Lymphocytes in Non-Hodgkin's Lymphoma
Smith B, Weinberg D, Robert N, Towle M, Luther E, Pinkus G, Ault K. Circulating Monoclonal B Lymphocytes in Non-Hodgkin's Lymphoma. New England Journal Of Medicine 1984, 311: 1476-1481. PMID: 6438505, DOI: 10.1056/nejm198412063112304.Peer-Reviewed Original ResearchConceptsMonoclonal B lymphocytesMonoclonal lymphocytesLight chain typeB lymphocytesHodgkin's lymphomaSensitive flow cytometric methodBone marrow involvementDiffuse histiocytic lymphomaProlonged clinical remissionNon-Hodgkin lymphomaForms of lymphomaCategory of lymphomaClinical remissionComplete remissionFlow cytometric methodClinical stagingProlonged remissionsHistologic subclassificationPrognostic importanceHistiocytic lymphomaRemissionPatient's diseasePatientsLymphomaClonal excess